- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: INCMGA00012 (PD-1 antibody)
Total 1098 results
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Xiangya Hospital of Central South University and other collaboratorsRecruitingNasopharyngeal CarcinomaChina
-
Sun Yat-sen UniversityShanghai Junshi Bioscience Co., Ltd.Active, not recruitingNasopharyngeal CarcinomaChina
-
Peking UniversityRecruitingHepatocellular Carcinoma | Portal Vein ThrombosisChina
-
Memorial Sloan Kettering Cancer CenterIncyte CorporationActive, not recruitingWell-differentiated/Dedifferentiated LiposarcomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI); Imugene LimitedActive, not recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Beijing Friendship HospitalNot yet recruitingLymphoma | Hemophagocytic Lymphohistiocytosis | PD-1 Antibody | Epstein-Barr VirusChina
-
Beijing Friendship HospitalNot yet recruitingHemophagocytic LymphohistiocytosisChina
-
Ruijin HospitalUnknownNasal Type Extranodal NK/T-Cell LymphomaChina
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalWithdrawn
-
Jinling Hospital, ChinaRecruitingNeoplasms | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Urologic Diseases | Carcinoma | Antineoplastic Agents | Male Urogenital Diseases | Female Urogenital Diseases | Immune Checkpoint Inhibitors | Urogenital DiseasesChina
-
Sun Yat-sen UniversityChipscreen Biosciences, Ltd.Not yet recruitingRelapsed or Refractory DLBCL
-
Beijing Tongren HospitalUnknown
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarotid Artery Plaque | Pd-1 InhibitorsChina
-
Beijing YouAn HospitalBeijing Gene Key Life Technology Co., Ltd.RecruitingHepatocellular CarcinomaChina
-
Agenus Inc.CompletedCervical Cancer | Advanced CancerFrance, United States, Belgium, Australia, Spain, Estonia, Brazil, Chile, Poland
-
Peking University First HospitalYiZhou International Cancer HospitalUnknownImmunotherapy | Proton Therapy
-
Jiangxi Provincial Cancer HospitalRecruiting
-
Dong WangNot yet recruiting
-
Shi MingWithdrawnHepatocellular CarcinomaChina
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.UnknownEsophageal CancerChina
-
Huabo Biopharm Co., Ltd.RecruitingTumor, SubjectsUnited States, China
-
Genentech, Inc.CompletedNeoplasmsUnited States, Spain, Belgium, Korea, Republic of, Canada, Australia, France
-
LiuYingNot yet recruitingColorectal Cancer | Neoadjuvant Therapy | Mismatch Repair-deficient (dMMR) | Microsatellite Instability-high (MSI-H)China
-
Jiangsu Cancer Institute & HospitalActive, not recruitingGastric or Gastroesophageal Junction AdenocarcinomaChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaThe University of Hong KongNot yet recruitingNon Small Cell Lung Cancer | Influenza VaccineChina
-
Zhejiang UniversityRecruitingHepatocellular CarcinomaChina
-
Robert L. Ferris, MD, PhDBristol-Myers SquibbRecruitingHead and Neck Squamous Cell Carcinoma (HNSCC)United States
-
Huiqiang HuangRecruitingHigh-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Non-GCB/ABC Diffuse Large B-Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Fudan UniversityRecruitingCholangiocarcinoma, IntrahepaticChina
-
Xiangya Hospital of Central South UniversityRecruitingColonic Neoplasms | Chemotherapy EffectChina
-
Hoffmann-La RocheCompletedTumorsFrance, United States, Denmark, Ireland, Italy, Turkey, United Kingdom, Canada, Brazil, Spain, Poland, Netherlands, Germany, Russian Federation, Austria, Finland, Norway, Switzerland
-
University of Colorado, DenverAstraZenecaWithdrawnPancreatic CancerUnited States
-
Shanghai Zhongshan HospitalRecruitingHepatocellular CarcinomaChina
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Zhejiang Cancer HospitalNot yet recruitingLocally Advanced Rectal CancerChina
-
Fudan UniversityRecruitingPeripheral T-cell LymphomaChina
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Locally Advanced Rectal CancerChina
-
University Hospital, BordeauxRecruitingMetastatic Renal Cell Carcinoma | Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC ScoreFrance
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Chinese PLA General HospitalLinkDoc Technology (Beijing) Co. Ltd.UnknownAdvanced Solid TumorsChina
-
Jason J. Luke, MDRecruitingMelanoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | Cholangiocarcinoma | Bladder Cancer | Renal Cancer | Anal Cancer | Merkel Cell Carcinoma | HNSCCUnited States
-
Changhai HospitalRecruitingPancreatic Neoplasms | Pancreatic Cancer | Advanced Cancer | Pancreatic Ductal AdenocarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLocally Advanced Non-Small Cell Lung CancerChina
-
University of OxfordVaccitech (UK) LimitedUnknownCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom
-
Han weidongUnknownMalignancies MultipleChina
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingRectal Squamous Cell CarcinomaChina
-
Shanghai Zhongshan HospitalRecruiting
-
Shanghai Zhongshan HospitalJining Medical University; Cancer Hospital of Guangxi Medical UniversityActive, not recruitingBiliary Tract CarcinomaChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarcinoma, HepatocellularChina